Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-20-003756
Filing Date
2020-04-09
Accepted
2020-04-09 16:01:55
Documents
8
Period of Report
2020-05-20
Effectiveness Date
2020-04-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a.htm DEF 14A 1957342
2 GRAPHIC def14ag001.jpg GRAPHIC 44794
3 GRAPHIC def14ag002.jpg GRAPHIC 122299
4 GRAPHIC def14ag003.jpg GRAPHIC 45394
5 GRAPHIC def14ag004.jpg GRAPHIC 10078
6 GRAPHIC def14ag005.jpg GRAPHIC 9985
7 GRAPHIC def14ag006.gif GRAPHIC 118768
8 GRAPHIC def14ag007.gif GRAPHIC 89353
  Complete submission text file 0001558370-20-003756.txt   2565903
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37372 | Film No.: 20784493
SIC: 2834 Pharmaceutical Preparations